6,8-Dichloro-3-methylimidazo[1,2-a]pyridine

Catalog No.: 
ACCTZW756
CAS No.: 
1545542-95-7
Molecular Formula: 
C8H6Cl2N2
Molecular Weight: 
201.06
6,8-Dichloro-3-methylimidazo[1,2-a]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$155.00InquiryInquiry
1g95%$443.00InquiryInquiry
5g95%$1287.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6,8-Dichloro-3-methylimidazo[1,2-a]pyridine
IUPAC Name6,8-dichloro-3-methylimidazo[1,2-a]pyridine
MDL No.MFCD24199827
Molecular FormulaC8H6Cl2N2
Molecular Weight201.06
SMILESCC1=CN=C2C(Cl)=CC(Cl)=CN21
InChI KeyWNYWQLJRDWITRU-UHFFFAOYSA-N
SynonymImidazo[1,2-a]pyridine, 6,8-dichloro-3-methyl-;6,8-dichloro-3-methylimidazo[1,2-a]pyridine
CAS No.1545542-95-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACCTZW756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRWCM710 route compound structure diagram
    ACRWCM7102065-66-9In Stock
  4. Then
  5. ACCTZW756 route product structure diagram
    ACCTZW7561545542-95-7
Inquiry

2. ACCTZW756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLMFA607 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCTZW756 route product structure diagram
    ACCTZW7561545542-95-7
Inquiry

3. ACCTZW756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCTZW756 route product structure diagram
    ACCTZW7561545542-95-7
Inquiry

Comments (0)